title: BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer.
abstract: BACKGROUND
  Gastric cancer is 2th most common cancer in China, and is still the second most common cause of cancer-related death in the world. How to recognize early gastric cancer cells is still a great challenge for early diagnosis and therapy of patients with gastric cancer. This study is aimed to develop one kind of multifunctional nanoprobes for in vivo targeted magnetofluorescent imaging of gastric cancer.
  
  
  METHODS
  BRCAA1 monoclonal antibody was prepared, was used as first antibody to stain 50 pairs of specimens of gastric cancer and control normal gastric mucous tissues, and conjugated with fluorescent magnetic nanoparticles with 50 nm in diameter, the resultant BRCAA1-conjugated fluorescent magnetic nanoprobes were characterized by transmission electron microscopy and photoluminescence spectrometry, as-prepared nanoprobes were incubated with gastric cancer MGC803 cells, and were injected into mice model loaded with gastric cancer of 5 mm in diameter via tail vein, and then were imaged by fluorescence optical imaging and magnetic resonance imaging, their biodistribution was investigated. The tissue slices were observed by fluorescent microscopy, and the important organs such as heart, lung, kidney, brain and liver were analyzed by hematoxylin and eosin (HE) stain method.
  
  
  RESULTS
  BRCAA1 monoclonal antibody was successfully prepared, BRCAA1 protein exhibited over-expression in 64% gastric cancer tissues, no expression in control normal gastric mucous tissues, there exists statistical difference between two groups (P < 0.01). The BRCAA1-conjugated fluorescent magnetic nanoprobes exhibit very low-toxicity, lower magnetic intensity and lower fluorescent intensity with peak-blue-shift than pure FMNPs, could be endocytosed by gastric cancer MGC803 cells, could target in vivo gastric cancer tissues loaded by mice, and could be used to image gastric cancer tissues by fluorescent imaging and magnetic resonance imaging, and mainly distributed in local gastric cancer tissues within 12 h post-injection. HE stain analysis showed that no obvious damages were observed in important organs.
  
  
  CONCLUSIONS
  The high-performance BRCAA1 monoclonal antibody-conjugated fluorescent magnetic nanoparticles can target in vivo gastric cancer cells, can be used for simultaneous magnetofluorescent imaging, and may have great potential in applications such as dual-model imaging and local thermal therapy of early gastric cancer in near future.
authors: Department of Bio-nano Science and Engineering, National Key Laboratory of Nano/Micro Fabrication Technology, Key Laboratory for Thin Film and Microfabrication of Ministry of Education, Institute of Micro-Nano Science and Technology, Shanghai Jiao Tong University, Shanghai 200240, China.
authors: Kan
authors: K
authors: Wang
authors: Jing
authors: J
authors: Ruan
authors: Qirong
authors: Q
authors: Qian
authors: Hua
authors: H
authors: Song
authors: Chenchen
authors: C
authors: Bao
authors: Xueqing
authors: X
authors: Zhang
authors: Yifei
authors: Y
authors: Kong
authors: Chunlei
authors: C
authors: Zhang
authors: Guohan
authors: G
authors: Hu
authors: Jian
authors: J
authors: Ni
authors: Daxiang
authors: D
authors: Cui
references: Biomaterials. 2008 Feb;29(6):692-702
references: 17996294
references: Genes Dev. 2003 Mar 1;17(5):545-80
references: 12629038
references: Comp Med. 2004 Dec;54(6):631-4
references: 15679260
references: Toxicol Lett. 2005 Jan 15;155(1):73-85
references: 15585362
references: Mol Pharm. 2010 Feb 1;7(1):94-104
references: 19891496
references: J Phys Chem B. 2006 Mar 23;110(11):5779-89
references: 16539525
references: Oncology. 2010;78(1):26-33
references: 20185938
references: World J Gastroenterol. 2001 Jun;7(3):403-6
references: 11819799
references: Nat Rev Cancer. 2002 Apr;2(4):266-76
references: 12001988
references: J Pathol. 2005 Jan;205(2):194-205
references: 15641018
references: Nanoscale Res Lett. 2010 Mar 23;5(5):875-81
references: 20672123
references: Magn Reson Imaging. 2006 Jun;24(5):611-7
references: 16735183
references: Small. 2010 Nov 5;6(21):2367-73
references: 20927799
references: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references: 18287387
references: World J Gastroenterol. 2005 Mar 7;11(9):1273-82
references: 15761963
references: Ann Oncol. 2008 Sep;19(9):1523-9
references: 18441328
references: Gene. 1991 Jul 22;103(2):171-7
references: 1889744
references: Nat Biotechnol. 2001 Apr;19(4):327-31
references: 11283589
references: Biomaterials. 2009 Sep;30(27):4786-95
references: 19520428
references: J Colloid Interface Sci. 2008 Jun 15;322(2):485-90
references: 18430431
references: J Nanosci Nanotechnol. 2010 Aug;10(8):4859-67
references: 21125820
references: Nanoscale Res Lett. 2011 Apr 06;6(1):299
references: 21711857
references: Mol Imaging Biol. 2006 Nov-Dec;8(6):315-23
references: 17053862
references: Int J Nanomedicine. 2011;6:425-35
references: 21499432
references: Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1136-45
references: 15247124
references: Anal Chem. 2008 Nov 1;80(21):7996-8001
references: 18816142
references: World J Gastroenterol. 2011 Mar 21;17(11):1501-6
references: 21472111
references: ACS Nano. 2008 Feb;2(2):197-202
references: 19206619
references: Nat Mater. 2005 Jun;4(6):435-46
references: 15928695
references: Biomaterials. 2011 May;32(13):3447-58
references: 21303717